The alpha6beta4 integrin promotes epithelial cell proliferation and migration and may play a pivotal role in carcinoma invasion. These functions are mediated by the unique and large cytoplasmic domain of beta4. We have recently shown that alpha6beta4 palmitoylated and interacts with the doubly acylated Src kinases Fyn and Yes in lipid rafts. Ligand binding activates Fyn/Yes, which in turn phosphorylates the C-terminal half of the beta4 tail, causing recruitment of the signaling adaptor protein Shc and thereby activation of ERK and possibly PI-3K. Upon dephosphorylation, the beta4 tail mediates assembly of hemidesmosomes. Recent studies have indicated that alpha6beta4 also associates with the receptor protein tyrosine kinases (RPTKs) EGF-R, ErbB-21Neu, Met, and Ret, and their activated oncogenic versions. Strong evidence points to cooperative signaling by Alpha6beta4 and these RPTKs. Our major goal is to clarify the mechanisms by which alpha6beta4 promotes cell proliferation and migration/invasion and to identify the physiological and pathological processes regulated by alpha6beta4 signaling in vivo.
In Aim 1, biochemical and microscopic methods will be used to examine the relationship between alpha6beta4 signaling and assembly of hemidesmosomes.
In Aim 2, cell biological methods will be used to examine the mechanisms underlying cooperative signaling by alpha6beta4 and associated RPTKs and to identify the downstream pathways that promote cell proliferation, migration, and invasion.
In Aim 3, the phenotype of mice carrying a targeted deletion of the signaling segment of the beta4 tail will be examined. Based on preliminary results, emphasis will be placed on the analysis of the signaling function of alpha6beta4 during postnatal angiogenesis.
In Aim 4, mouse molecular genetics methods will be employed to study the role of alpha6beta4 in tumor invasion. The targeted deletion of the signaling domain of beta4 will be introduced in mice genetically engineered to develop carcinomas of the skin (K14-I-IPV16 and K14-SOS-F transgenic mice), mammary gland (MMTV-Neu and MT1-Trp-Met mice), and thyroid gland (TG-Ret/PTC3 mice). Analysis of tumor growth and invasion and tumor angiogenesis in these mice will reveal if alpha6beta4 signaling plays a role in these processes. By using both cell biology and genetics, we hope to achieve a better understanding of the signaling function of this important integrin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA058976-12
Application #
6731150
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Macleod, Carol L
Project Start
1994-01-01
Project End
2008-02-29
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
12
Fiscal Year
2004
Total Cost
$356,625
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Fan, Jie; Cai, Bin; Zeng, Min et al. (2011) Integrin ?4 signaling promotes mammary tumor cell adhesion to brain microvascular endothelium by inducing ErbB2-mediated secretion of VEGF. Ann Biomed Eng 39:2223-2241
Pylayeva, Yuliya; Gillen, Kelly M; Gerald, William et al. (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119:252-66
Oktay, Kutluk; Buyuk, Erkan; Oktem, Ozgur et al. (2008) The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis. Cell Cycle 7:533-41
Pylayeva, Yuliya; Guo, Wenjun; Giancotti, Filippo G (2007) Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression. Methods Enzymol 426:439-61
Guo, Wenjun; Pylayeva, Yuliya; Pepe, Angela et al. (2006) Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126:489-502
Nikolopoulos, Sotiris N; Blaikie, Pamela; Yoshioka, Toshiaki et al. (2005) Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol 25:6090-102
Nikolopoulos, Sotiris N; Blaikie, Pamela; Yoshioka, Toshiaki et al. (2004) Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6:471-83
Gagnoux-Palacios, Laurent; Dans, Michael; van't Hof, Wouter et al. (2003) Compartmentalization of integrin alpha6beta4 signaling in lipid rafts. J Cell Biol 162:1189-96
Wary, K K; Mariotti, A; Zurzolo, C et al. (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-34
Mainiero, F; Murgia, C; Wary, K K et al. (1997) The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16:2365-75

Showing the most recent 10 out of 12 publications